Post by
stockfy on Jan 28, 2021 5:08pm
APHA with Cipher Pharmaceuticals (CPH)?
Given that the combined company APHA-TLRY will sell medicinal cannabis, I believe it could make a deal with Cipher Pharmaceuticals (CPH), which has a lot of expertise in many dermatological products.
For instance, CPH produces excellent creams for acne (i.e. its well-known Epuris has 41% market share in Canada), so CPH could make a topical ointment with medicinal cannabis for skin issues too.
Better yet, I wish APHA acquired CPH now because CPH is profitable and dirt-cheap trading just 1.3 times its EBITDA.
And the thing is that CPH has many levers to pull for revenue growth in 2021 because it has many promising drugs in the pipeline with very positive clinical trials to-date.
Comment by
IrishCanuck on Jan 28, 2021 5:36pm
Dawg we don't need Cipher's tattoo removal product in Aphria's portfolio just like we're not looking to get into bed with David's Tea. What are you talking about? BMW doesn't make surf boards just because technically it counts as a mode of transportation. How big into CPH are you that you're pushing it on all the boards lmao
Comment by
optimi$tic on Jan 28, 2021 6:15pm
with more people working remotely and not having to face co-workers or clients guess what? Tattoos are coming back strong than ever especially with more disposable income from not being able to spend on travel sex entertainment list goes on.